Shaping the Future of Evidence-Based Healthcare at ISPOR Europe 2025

Events

2025, 13 October

– 1 min read

Shaping the Future of Evidence-Based Healthcare at ISPOR Europe 2025

At Quinten Health, we believe that AI and data science can transform how evidence is produced, interpreted, and used by healthcare stakeholders. Through our solutions, we enable regulators, payers, and life sciences organizations to access actionable and transparent insights.

This year at ISPOR Europe, we are proud to contribute to the global conversation on the use of advanced analytics in HEOR with six poster presentations.

Six Posters at ISPOR Europe 2025

Our team will present six studies that explore cutting-edge applications of AI and machine learning for real-world data analysis, evidence synthesis, and methodological innovation:

1. An AI-Powered Tool to Identify and Assess Fit-for-Use Registries for Drug Development and Evaluation (RWD16)

Date/Time: Monday, 10 November, 10:30 AM – 01:30 PM
Presenter: Ghinwa Hayek
Exploring how AI can streamline the identification and assessment of RWD for regulatory and HTA purposes.

2. A new regulatory-grade chronic disease cohort simulator: leveraging the large, deep and long CONSTANCEs cohort linked and matched to the SNDS in France (MSR7)

Date/Time: Monday, 10 November, 10:30 AM – 01:30 PM
Presenter: Marie Génin
Creating large-scale chronic disease cohorts for simulation and HTA applications.

3. Comparing Individualized Treatment Effect Inference Methods Through A Simulation Study (MSR58)

Date/Time: Monday, 10 November, 04:00 PM – 07:00 PM
Presenter: Antoine Movschin
Benchmarking causal inference methods to infer personalized treatment effects from observational data.

4. Development of an AI-Powered Tool to Accelerate and Enhance Systematic Literature Reviews for Evidence-based Decision-Making in Clinical Research (MSR72)

Date/Time: Monday, 10 November, 04:00 PM – 07:00 PM
Presenter: Paul Loustalot
Using AI to enhance efficacy of systematic literature reviews, while preserving methodological rigor.

5. Comparative Evaluation of Sequence Encoding Strategies for Clustering Inhaled Therapy Pathways in COPD Patients Using Real-World Data (MSR56)

Date/Time: Monday, 10 November, 04:00 PM – 07:00 PM
Presenter: Marie Génin
Investigating patient trajectories and therapy patterns through sequence analysis.

6. Evaluating Bayesian Borrowing Methods for Treatment Effect Extrapolation: A Simulation-based Study (MSR91)

Date/Time : Tuesday, 11 November, 10:30 AM – 01:30 PM
Presenter: Antoine Movschin
Comparing Bayesian methods for treatment effect extrapolation in diverse settings.

Meet Us at Booth #513

Visit us at Booth #513 to meet the Quinten Health team, experience our AI-powered solutions in action, and discuss how we help bridge the gap between data science and real-world evidence across the drug development lifecycle. Our experts will be available throughout the conference to exchange ideas, discuss collaborations, and dive into methodology.

Join the Conversation

We look forward to connecting with researchers, decision-makers, and innovators shaping the future of health economics and outcomes research.

Let’s advance evidence-based healthcare together.

About ISPOR Europe 2025

November 9–12, 2025
Glasgow, Scotland, UK
Theme: Powering Value and Access Through Patient-Centered Collaboration
Focus: The conference spotlights how patient perspectives integrated into value assessments, pricing, reimbursement, and market access strategies can drive equitable, sustainable healthcare solutions.
Audience: Global leaders, researchers, decision-makers in HEOR, including academia, industry, payers, providers, regulators, and patient groups.
Program: A mix of keynotes, plenary sessions, poster presentations, short courses, and interactive discussions on current challenges in HEOR.